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Thyroid transcription factor-1 (TTF-1), a member of the Nkx2 family of homeodomain-containing transcription factors, is
expressed in the epithelium of the lung. TTF-1 is a critical regulator of transcription for the surfactant proteins (SP) A, B,
and C and is essential for lung morphogenesis. Sites and levels of TTF-1 expression vary during lung morphogenesis and
following injury. In order to determine the role of TTF-1 in lung formation, transgenic mice were generated in which TTF-1
was expressed in respiratory epithelial cells of wild-type and Ttf1 null mutant (2/2) mice, using the lung-specific SP-C
promoter. The SP-C-Ttf1 transgene did not rescue the severe pulmonary hypoplasia characteristic of the Ttf1 (2/2) mice.
Increased expression of TTF-1, however, caused dose-dependent alterations in postnatal lung morphology of wild-type mice.
Modest overexpression of TTF-1 caused type II cell hyperplasia and increased the cellular content of SP-B. In contrast,
higher expression levels of TTF-1 disrupted alveolar septation, causing emphysema. In mice with the highest transgene
expression, TTF-1 caused severe inflammation, pulmonary fibrosis, respiratory failure, and death, associated with
eosinophil infiltration and increased expression of eotaxin and IL-6. Increased expression of TTF-1 altered alveolarization
and caused chronic pulmonary inflammation, demonstrating that precise regulation of TTF-1 is critical for homeostasis in
the postnatal lung. © 2002 Elsevier Science (USA)
Key Words: mouse lung; morphogenesis; Nkx2.1; TITF-1; T/EBP; surfactant protein B; eosinophils; eotaxin; IL-6;
emphysema.INTRODUCTION
Thyroid transcription factor-1 (TTF-1, TITF-1, T/EBP,
Nkx2.1) is a 43-kDa member of the Nkx2 family of
homeodomain-containing proteins and is selectively ex-
pressed in the forebrain, thyroid, and lung. TTF-1 is re-
quired for lung and thyroid morphogenesis (Kimura, 1996;
Lazzaro, 1991; Minoo, 1999) and for the expression of genes
selectively expressed in the respiratory epithelium of the
lung (Whitsett, 1998). TTF-1 is expressed during early
formation of the lung, the temporal–spatial regulation of
TTF-1 production being precisely regulated throughout
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All rights reserved.lung development (Morotti, 2000; Stahlman, 1996; Zhou,
1996a, 2001). TTF-1 expression is most abundant in epithe-
lial cells of the developing pulmonary tubules, decreasing in
the proximal conducting airways with advancing gesta-
tional age. Expression of TTF-1 is increased by transcription
factors HNF-3b and GATA-6, and is induced by members of
the fibroblast growth factor (FGF) family of polypeptides,
including FGF-7 and FGF-10 (Clark, 2001; Ikeda, 1996;
Shaw-White, 1999; Tichelaar, 2000). The levels of TTF-1
protein decrease markedly in late gestation and in the
postnatal period of development (Morotti, 2000; Stahlman,
1996; Zhou, 2001). TTF-1 is expressed primarily in type II
epithelial cells, less abundantly in subsets of nonciliated
respiratory epithelial cells and basal cells in the conducting
airways, and is not expressed in type I cells (Morotti, 2000;
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76 Wert et al.Stahlman, 1996; Zhou, 1996a, 2001). In the postnatal lung,
TTF-1 is required for transcription of surfactant proteins
(SP) A, B, and C, as well as the Clara cell secretory protein
(CCSP) (Bohinski, 1994; Bruno, 1995; Kelly, 1996; Toonen,
1996; Zhang, 1997).
Lungs from Ttf1 null mutant (2/2) mice consist of
tracheal and bronchial tubules, with nearly complete loss of
peripheral lung parenchyma, supporting the concept that
TTF-1 plays an important role in lung morphogenesis
(Kimura, 1996; Minoo, 1999). Since TTF-1 is also expressed
in the lung after injury, TTF-1 may play a role in epithelial
cell proliferation and differentiation during the repair pro-
cess. While TTF-1 staining decreases in sites of acute
epithelial injury, TTF-1 is markedly increased in regions of
lung parenchyma undergoing regeneration and repair (Stahl-
man, 1996). Taken together, these findings support the
concept that precise temporal–spatial regulation of TTF-1
may be important to the normal cytodifferentiation of the
epithelium, which accompanies lung morphogenesis and
repair following injury. In order to further discern the role of
TTF-1 in pulmonary morphogenesis and function, a series
of transgenic mice were generated in which the rat TTF-1
cDNA was overexpressed in respiratory epithelial cells.
Increased copies of the SP-C-Ttf1 transgene caused dose-
dependent changes in alveolarization and inflammation of
the lung.
METHODS
Generation of SP-C-Ttf1 Transgenic Mice
A 1.26-kb fragment containing the entire coding region of the rat
TTF-1 cDNA (Guazzi, 1990) (the kind gift of Dr. Roberto DiLauro)
was subcloned into a PUC-18 plasmid vector containing the human
3.7 SP-C promoter and SV40 t intron-poly(A) sequences (Fig. 1A).
The transgene was propagated in Escherichia coli DH 5a cells, and
the fragment was excised and purified by using the QIAEX DNA
extraction kit (Qiagen Inc., Chatsworth, CA), as described by the
manufacturer. After extensive dialysis, the linearized fragment was
microinjected into the pronucleus of fertilized eggs from FVB/N
mice. Transgenic mice were identified by PCR and Southern blot
analyses. PCR products were designed to include TTF-1 cDNA and
the SV40 t intron-poly(A) region (TPA) to ensure specificity for
identification of the transgene. Southern blot analysis was per-
formed, after restriction fragment digestion with EcoRI, to confirm
the presence and size of the transgene using the TPA probe for
hybridization. To estimate DNA copy number, Southern blot
analysis was performed by using a 1.2-kb TTF-1 cDNA fragment as
the probe. Quantitation was performed by phosphorimaging (Storm
860; Molecular Dynamics, Sunnyvale, CA). Phosphorimage units
for the transgene were normalized to that for the endogenous Ttf1
gene, and the average density ratios for each transgenic line were
compared to estimate relative DNA copy number. Two permanent
founder lines of SP-C-Ttf1 transgenic mice, one with multiple
copies of the transgene (Hi) and one with a single copy of the
transgene (Lo), were established and maintained in the vivarium.
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All mice were maintained in a barrier facility, and animals were
handled under IACCAC approved protocols. There was no sero-
logic evidence of viral pathogens or bacterial infections in sentinal
mice maintained with the colony. No serological evidence of viral
infection or histological evidence of bacterial infection was de-
tected in transgenic mice at necropsy. All genotypes were main-
tained in the FVB/N strain. DNA copy number and levels of Ttf1
transgene expression were altered by crossing the separate Hi (1/2)
and Lo (1/2) transgenic lines to produce Hi (1/2), Lo (1/2) and Hi
(1/2), Lo (1/1) bitransgenic mice. The Ttf1 (2/2) mice were
originally generated in C57BL/6N (B6), 129S4/5vJae mice in the
laboratory of Dr. Kimura at the National Institutes of Health
(Kimura, 1996), maintained as heterozygotes (1/2), and bred to the
SP-C-Ttf1 transgenic line, Hi (1/2), to generate Ttf1 (2/2), SP-C-
Ttf1 (1/2) mice.
mRNA Analysis
Northern blot analysis, using the [32P]-labeled 0.47-kb TPA
fragment from the transgene as a probe, was performed with
mRNA isolated from the lungs of transgenic mice and wild-type
littermate controls. A full-length TTF-1 cDNA probe was used to
detect endogenous mouse TTF-1 mRNA. Mouse SP-C mRNA was
detected by using a radiolabeled, full-length, 0.9-kb SP-C cDNA
probe.
Histology and Immunohistochemistry
Tissue sections were prepared from fetal (E18–E18.5), neonatal
(newborn, postnatal days 7 and 14), juvenile (postnatal days 21 and
28), and adult lungs fixed with 4% paraformaldehyde in phosphate-
buffered saline (PBS). To obtain fetal tissue, dams were anesthe-
tized with a 4:1:1 mixture of ketamine, acepromazine, and xylazine
and then exsanguinated by severing the inferior vena cava and
descending aorta. The fetuses were removed by hysterotomy and
bisected below the diaphragm, which was stripped away from the
rib cage, before immersion in fixative overnight. Postnatal animals
were anesthetized, weighed, and then exsanguinated as described
above. The trachea was cannulated, and the lungs were collapsed
by piercing the diaphragm. The lungs were inflation-fixed at 25 cm
of water pressure for 1 min. Tissue was immersion-fixed overnight,
washed in PBS, dehydrated through a series of alcohols and xylenes,
and embedded in paraffin. Tissue sections were stained with
hematoxylin and eosin, Masson’s trichrome stain, and orcein in
order to analyze histopathological changes in the tissue. Immuno-
histochemistry for eosinophil major basic protein (Matthews,
1998), TTF-1, SP-B, SP-C preproprotein (proSP-C), and proliferating
cell nuclear antigen (PCNA) (clone PC10, Zymed Laboratories Inc.,
South San Francisco, CA) was performed as described previously
(Zhou, 1996a), using biotinylated primary or secondary antibodies
and avidin-biotin-peroxidase (Vector Elite ABC kit; Vector Labora-
tories Inc., Burlingame, CA) or strepavidin (Zymed Laboratories)
detection systems. The enzymatic reaction was enhanced with
nickel cobalt, and the sections were 2counterstained with nuclear
fast red. Elimination of the primary antibody from the reaction
served as a negative control for nonspecific binding of the second-
ary antibody, as well as for other kit components. Mouse intestine
and esophagus were used as positive controls for the PCNA
reaction; normal adult mouse lung served as a negative control for
this cellular proliferation assay.
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Expression of SP-C-Ttf1 transgene mRNA was assessed by in
situ hybridization using [35S]-labeled TPA riboprobes, as previously
described (Wert, 1993; Zhou, 1996b). Tissue sections were hybrid-
ized overnight at 42°C, washed, treated with 20 mg/ml of RNAse
for 10 min at room temperature, dehydrated, and coated with
Kodak NTB2 emulsion. Slides were autoradiographed for 2–6
weeks before being developed with Kodak D19 developer. Results
were photographed with darkfield illumination.
Protein Measurements
Mice were anesthetized and exsanguinated as described above.
The trachea was cannulated, and the lungs were lavaged three
FIG. 1. SP-C-Ttf1 transgenic construct, genomic integration, an
SP-C-Ttf1 transgene. A 1.26-kb fragment of the coding region of ra
site of a PUC-18 plasmid vector, between the human 3.7 SP-C prom
and polyadenylation signal are indicated. Arrowheads indicate the s
TPA fragment used to generate probes for DNA, mRNA, and in
analysis of transgene integration and germ line transmission. Tail D
TPA probe. The 4.4-kb band represents transgenic DNA that integra
represents integration of a single copy of the transgene into the Lo
copy founder lines to produce Hi (1/2), Lo (1/2) bitransgenic mou
line. (C) Northern blot analysis of transgene expression in the lung
probe was performed to confirm transgene expression in the lung.
founder line (lane 3) compared with the Lo (1/2) copy founder line (
control; Lane 3, Hi (1/2) copy founder line. (D) Northern blot ana
of total lung mRNA using a [32P]-labeled TTF-1 probe was performed
in the Hi (1/2) copy founder line. Transgenic TTF-1 mRNA expres
mice (lane 1). Endogenous levels of TTF-1 and SP-C mRNA in transg
(lane 2). Lane 1, Hi (1/2) copy founder line; Lane 2, nontransgenictimes with 1-ml aliquots of sterile PBS. Bronchoalveolar lavage
© 2002 Elsevier Science (USAfluid (BALF) for each animal was pooled, and the volumes were
measured. The cells were removed by centrifugation and the
samples were stored at 220°C. SP-B content was measured by
enzyme-linked immunosorbent assay (ELISA), using bovine SP-B as
the standard, and was expressed as ng/mg of protein (Pryhuber,
1991). Total protein in the pooled samples was determined accord-
ing to the method of Lowry et al. (1951), using bovine serum
albumin as the standard. Eotaxin content was quantitated as
previously described, using mouse eotaxin as the quantitation
standard (Mishra, 2001), and expressed as pg/ml of BALF. Tumor
necrosis factor-a (TNF-a), interleukin (IL)-1b, IL-6, and macrophage
inflammatory protein-2 (MIP-2) levels were quantitated by using
murine sandwich ELISA kits (R&D Systems, Minneapolis, MN),
according to the manufacturer’s directions, and expressed as mg or
NA expression in the lung. (A) Construction of the human 3.7
F-1 cDNA was inserted into an EcoRI site in the multiple cloning
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representative of n . 4 animals per genotype. Original magnification for all panels, 4403.
79Effects of TTF-1 on AlveolarizationFIG. 2. Histopathology of transgenic and bitransgenic mouse lung. Both heterozygous Lo (1/2) and homozygous Lo (1/1) transgenic mice had
normal appearing lungs with no evidence of inflammation or alveolar remodeling (data not shown). Heterozygous Hi (1/2) mice (A) also had
normal-appearing lungs compared with their nontransgenic littermate controls (B). Enlarged, emphysematous alveoli were found throughout the lung
in the heterozygous Hi (1/2), Lo (1/2) bitransgenic mice (C). Eosinophilic infiltrates with focal areas of fibrosis (arrow) were found throughout the lungs
of bitransgenic mice heterozygous for the Hi (1/2) copy transgene and homozygous for the Lo (1/1) copy transgene (D). Perivascular infiltrates were
also found in the latter genotype (not shown). Figures are representative of n . 4 individual animals per genotype. Original magnification for all panels,
1103.
FIG. 3. Immunohistochemistry for TTF-1. TTF-1 was detected by immunostaining with a rabbit polyclonal antibody generated to rat TTF-1, as
described in Methods. TTF-1 was detected as a black precipitation product in the nuclei of alveolar type II cells (arrows) in both wild-type (WT) littermate
controls (A) and Lo (1/2) transgenic mice (B). TTF-1 immunopositive cells were distributed throughout the lung at a ratio of one to two cells per alveoli
in both WT and Lo (1/2) transgenic mice. In Hi (1/2) transgenic mice, TTF-1 staining was detected in clusters of two to four type II cells per alveoli
(arrow), indicating a mild hyperplasia of the alveolar cells expressing this transgene (C). Enlarged alveoli with decreased TTF-1 staining of the remaining
alveolar type II cells were detected in the lungs of bitransgenic Hi (1/2), Lo (1/2) bitransgenic mice (D), although clusters of two to three TTF-1-positive
cells were found occasionally (arrow). Increased staining for TTF-1 was detected in the nuclei of type II cells (arrow) adjacent to focal areas of macrophage
accumulation (arrowhead) (E) and at the pleural surface (F). In bitransgenic Hi (1/2), Lo (1/1) bitransgenic mice, clusters of TTF-1-positive type II cells
(arrows) were detected in focal areas of emphysema (G) and fibrosis (H), but not in regions of acute eosinophilic inflammation (I). Figures areFIG. 4. Immunohistochemistry for SP-B. SP-B was detected by immunostaining with a rabbit polyclonal antibody to the mature, hydrophobic SP-B
peptide as described in Methods. SP-B was detected as a black precipitation product in the cytoplasm of alveolar type II cells (arrows) throughout the
lungs of both wild-type (WT) littermate controls (A) and Lo (1/2) transgenic mice (B). SP-B-positive cells were distributed in a ratio of one to two cells
per alveoli, similar to that for TTF-1-positive cells in these genotypes. Increased cytoplasmic staining for SP-B was detected in clusters of alveolar type
II cells (arrows) found in the Hi (1/2) transgenic mice (C). Enlarged alveoli with decreased staining for SP-B (arrow) were found in the Hi (1/2), Lo (1/2)
bitransgenic mice (D), although increased staining for SP-B could still be found in alveolar type II cells (arrows) adjacent to focal areas of macrophage
infiltration (arrowheads) (E and F). Increased staining for SP-B was detected in alveolar type II cells (arrows) of the Hi (1/2), Lo (1/1) bitransgenic mice,
as well as in alveolar macrophages (arrowheads) (G). Increased staining for SP-B was detected in secreted, proteinaceous material (arrows) found in focal
areas of fibrosis, while decreased staining for SP-B (arrows) was found in regions of acute eosinophilic inflammation (arrowheads) (I). Figures arerepresentative of n . 4 animals per genotype. Original magnification for all panels, 4403.
© 2002 Elsevier Science (USA). All rights reserved.
80 Wert et al.495 nm, and the results were determined with the use of computer-
assisted analysis.
Statistical Analysis
Data are expressed as the mean 6 SEM. Statistical significance
was determined by using the Student’s t test for comparison of SP-B
concentrations in BALF, the Mann–Whitney test for comparison of
eotaxin levels in BALF (due to unequal variances in the comparison
groups), and analysis of variance followed by the Student–
Newman–Keuls multiple comparison test for analysis of the total
number of cells recovered in BALF from bitransgenic and control
mice.
RESULTS
Two separate SP-C-Ttf1 founder lines with high (Hi) and
low (Lo) levels of transgene expression were generated and
maintained in the FVB/N strain. The transgene were main-
tained in SP-C-Ttf1 heterozygous (1/2) mice. Southern blot
analysis was used to determine germ line transmission (Fig.
1B) and to demonstrate increased copy number of the
transgene in each line. Phosphorimaging was used to esti-
mate copy numbers, which were approximately three cop-
ies in the Hi (1/2) and four copies in the Hi (1/2),Lo (1/2)
bitransgenic lines when compared to the single copy Lo
(1/2) transgenic line (n 5 3–4 animals per genotype; data
not shown). Northern blot analysis using the TPA probe
was performed to compare the expression of transgene
mRNA in the lungs of both Hi (1/2) and Lo (1/2) copy
founder lines (Fig. 1C). Transgenic mRNA expression was
greater in the Hi (1/2) copy line compared with the Lo
(1/2) copy line. Northern blot analysis, using the rat TTF-1
probe, demonstrated that expression of the Ttf1 transgene
mRNA species appeared to be higher than that of the
endogenous TTF-1 mRNA in the Hi (1/2) copy line (Fig.
1D). Endogenous levels of SP-C mRNA in transgenic mice
were comparable to those observed in nontransgenic con-
trols (Fig. 1D). While lung histology in the Lo (1/2), Lo
(1/1), and Hi (1/2) transgenic mice was relatively unal-
tered, dramatic histologic changes were evident in both Hi
(1/2), Lo (1/2) and Hi (1/2), Lo (1/1) bitransgenic mice
(Fig. 2). The severity of the abnormalities varied with
transgene dosage. Bitransgenic Hi (1/2), Lo (1/1) mice
failed to thrive and did not live beyond 3–4 weeks of age.
Animals with the Hi (1/1) genotype were almost never
encountered in the colony. Lung histology of a single Hi
(1/1) transgenic mouse available for analysis demonstrated
severe emphysema and pulmonary fibrosis (data not
shown).
Histology and Immunohistochemistry for TTF-1
and SP-B
While no clear abnormalities were seen by histologic
assessment of lungs from adult Lo (1/2), Lo (1/1), or Hi
© 2002 Elsevier Science (USA(1/2) transgenic mice when compared with wild-type lit-
termates, abnormalities in lung morphology were readily
observed in the bitransgenic mice (Fig. 2). Increased num-
bers of type II epithelial cells were observed in the Hi (1/2)
transgenic mice, often appearing as abnormal clusters of
type II cells whose nuclei stained intensely for TTF-1 (Fig.
3C). Lung histology was more severely disrupted in both the
Hi (1/2), Lo (1/2) and Hi (1/2), Lo (1/1) bitransgenic
mice. Lungs of Hi (1/2), Lo (1/2) bitransgenic mice were
clearly abnormal, consisting of emphysematous lesions
with poor alveolar septation (Fig. 2C), as well as a paucity of
type II cells with decreased TTF-1 staining (Fig. 3D). Robust
staining for TTF-1 was detected, however, in alveolar type II
cells located adjacent to focal regions of increased macro-
phage infiltration and in prefibrotic lesions at the periphery
of the lung (Figs. 3E and 3F). Even more dramatic abnor-
malities in lung morphology were noted in the Hi (1/2), Lo
(1/1) bitransgenic mice. These lungs were markedly em-
physematous and infiltrated with macrophages and eosino-
phils (Fig. 2D). Interstitial thickening and fibrosis were
observed in the lung periphery. Regions of hyperplastic type
II cells staining intensely for TTF-1 were noted in both
emphysematous and fibrotic lesions (Figs. 3G and 3I).
Absent and/or decreased TTF-1 staining was observed,
however, in regions of severe inflammation (Fig. 3H).
Differences in the staining patterns for SP-B expression
correlated with that for TTF-1 in all genotypes. Robust
cellular expression of SP-B was found by immunohisto-
chemistry in alveolar type II cells of wild-type, Lo (1/2),
and Hi (1/2) transgenic mouse lungs (Figs. 4A–4C). In-
creased cellular staining for SP-B was detected in the
clusters of hyperplastic type II cells found in the Hi (1/2)
transgenic mice (Fig. 4C). Cellular staining for SP-B was
absent or decreased in emphysematous regions of bitrans-
genic Hi (1/2), Lo (1/2) mouse lungs (Fig. 4D), similar to
that observed for TTF-1 staining, while SP-B staining was
maintained or increased in alveolar type II cells adjacent to
foci of alveolar macrophage accumulation and in prefibrotic
lesions found at the periphery of the lung (Figs. 4E and 4F).
Staining for SP-B was decreased or absent in regions of
severe eosinophil infiltration in the Hi (1/2), Lo (1/1)
bitransgenic mice (Fig. 4I), but was maintained or increased
in alveolar type II cells located in noninflamed regions of
the lung (Fig. 4G), correlating with TTF-1 expression in
these foci. SP-B-positive alveolar macrophages and secreted
proteinaceous material were found throughout the lungs of
the Hi (1/2), Lo (1/1) bitransgenic mice (Figs. 4G and 4H),
suggesting increased synthesis and secretion of SP-B. This
was confirmed by quantitative analysis of the SP-B content
of BALF from the Hi (1/2), Lo (1/1) bitransgenic mice.
SP-B concentration in the BALF of postnatal day-21, Hi
(1/2), Lo (1/1) bitransgenic mice was elevated signifi-
cantly compared with age-matched, nontransgenic con-
trols: 95.4 6 17.9 ng/mg protein (n 5 4) vs. 43.3 6 9.85
ng/mg of protein (n 5 5), respectively (P 5 0.025).
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BALF from postnatal day-21 and -28 Hi (1/2), Lo (1/1)
bitransgenic mice contained increased numbers of eosino-
phils, large foamy macrophages, and neutrophils, consistent
with the histopathologic findings (Fig. 5). Differential cell
counts revealed a significant increase in eosinophils (70%),
with a modest increase in neutrophils (5%), when compared
with that for nontransgenic littermates, in which 98% of
the cells were macrophages and ,2% were neutrophils
(Jain-Vora, 1997). The total number of inflammatory cells
was markedly increased from 4.8 6 0.4 3 104 cells in the
nontransgenic controls to 3.4 6 0.5 3 105 cells in the Hi
(1/2), Lo (1/1) bitransgenic mice, (P 5 0.03; n 5 3 for
each genotype). Inflammation was associated with in-
creased production of eotaxin, an eosinophil-selective che-
moattractant normally produced by pulmonary epithelial
cells (Rothenberg, 1999). Eotaxin levels in the BALF from
the Hi (1/2), Lo (1/2) bitransgenic mice were 3840 6 2460
pg/ml (n 5 9) vs. 194 6 32 pg/ml (n 5 5) for the
nontransgenic control mice (P 5 0.001). Similarly, IL-6
was markedly increased in the BALF of the Hi (1/2), Lo
(1/1) bitransgenic mice to 430.5 6 77 pg/ml (n 5 5), being
undetectable in the controls (n 5 8). Extremely low levels
of IL-1b (5.5 6 2 pg/ml) and MIP-2 (3.15 6 1.5 mg/ml) were
observed in the BALF of the Hi (1/2), Lo (1/1) bitransgenic
mice (n 5 5), while neither cytokine was detectable in the
controls (n 5 8). TNF-a was not detected in the BALF from
either genotype.
Cellular Proliferation
Because type II cell hyperplasia, emphysema, and fibrosis
were noted in the histologic studies, immunohistochemis-
try for PCNA was used to determine whether proliferative
activity was increased in the pulmonary epithelium. In
general, PCNA staining was not detected in the alveolar
epithelium of wild-type, Lo (1/2), or Hi (1/2) transgenic
mice (data not shown). In the lung periphery, foci of
PCNA-positive alveolar type II cells admixed with PCNA-
positive cells with condensed nuclei were detected in the
Hi (1/2), Lo (1/2) bitransgenic mice (Figs. 6A and 6B).
Large, emphysematous alveoli with no PCNA staining were
found in the centrolobular regions of these lungs (Fig. 6F).
This pattern of PCNA expression suggests that increased
cellular proliferation followed by rapid cell death might
account for the loss of alveolar epithelium in these mice,
which results in emphysema. On the other hand, robust
nuclear staining for PCNA was detected in a variety of cells
found throughout the lungs of the Hi (1/2), Lo (1/1)
bitransgenic mice, i.e., in alveolar type II cells, in inflam-
matory cells, and in presumptive fibroblasts located in focal
regions of fibrosis (Figs. 6D–6F). This reactive, hyperplastic
pattern of PCNA staining in alveolar type II cells correlates
with that for TTF-1 and SP-B staining shown previously in
these cells. This suggests that high levels of TTF-1 may be
involved in reparative and/or proliferative responses to
acute and/or chronic inflammation in the lung.
© 2002 Elsevier Science (USADevelopment of TTF-1 Induced Lesions
In order to assess whether TTF-1 altered lung morpho-
genesis during fetal development or caused alterations in
postnatal alveologenesis, lung histology was compared in
fetal mice at E18.5 and in postnatal mice at day 14. At
E18.5, lung morphology of all genotypes was normal, and no
difference in TTF-1, SP-B, or PCNA staining were detected
(data not shown). Abnormalities in alveolar structure were
detected in the Hi (1/2) transgenic mice and in both the Hi
(1/2), Lo (1/2) and Hi (1/2), Lo (1/1) bitransgenic mice at
postnatal day 14, indicating that overexpression of TTF-1
perturbed alveolarization (Fig. 7). Alveologenesis appeared
to be delayed in the 14-day-old Hi (1/2) transgenic mice
(Fig. 7B) compared with the adult Hi (1/2) transgenic
mouse lung (Fig. 2A), while enlarged, emphysematous al-
veoli and inflammation were detected in both the Hi (1/2),
Lo (1/2) and Hi (1/2), Lo (1/1) bitransgenic mice at 14
days of age (Figs. 7C and 7D).
In Situ Hybridization for the TTF-1 Transgene
In order to detect exogenous transgene expression in
lungs of the SP-C-Ttf1 transgenic mice, a unique sequence
from the 39 region of the SP-C-Ttf1 transgene, containing
the TPA, was utilized as an in situ hybridization probe.
Transgene mRNA was detected in most type II epithelial
cells in lungs of both Lo (1/2) and Hi (1/2) transgenic mice
(Figs. 8B and 8C), consistent with the known cellular
expression of the 3.7 human SP-C promoter element used in
the construct (Wert, 1993). Transgene expression was more
abundant in the Hi (1/2) transgenic mice than in the Lo
(1/2) transgenic mice, consistent with the Northern blot
analysis, immunohistochemistry for TTF-1 and SP-B, and
with the increased copy number of transgenic DNA ob-
served in the Hi vs. Lo transgenic lines. Expression of the
transgene was also readily detected in both the Hi (1/2), Lo
(1/2) and Hi (1/2), Lo (1/1) bitransgenic mice (Figs. 8D
and 8E), although the transgene mRNA was not uniformly
distributed. Transgene mRNA was detected in areas of lung
hyperplasia and fibrosis, but was decreased in areas of the
lung with severe inflammation and emphysema, consistent
with immunohistochemical localization of TTF-1 protein.
SP-C-Ttf1 Fails to Rescue Pulmonary Hyperplasia
in Ttf1 (2/2) Mice
In order to assess whether the expression of TTF-1 by the
SP-C promoter might rescue the Ttf1 (2/2) mice during
fetal development, the Hi (1/2) transgenic mice were bred
to heterozygous Ttf1 (1/2) mice to generate Ttf1 (2/2),
SP-C-Ttf1 (Hi 1/2) transgenic mice. The lung phenotype of
these mice was similar to that of the Ttf1 (2/2) mice,
demonstrating a lack of correction of the severe pulmonary
hypoplasia found in these animals by insertion of the
SP-C-Ttf1 transgene (data not shown). This result is consis-
tent with the requirement of TTF-1 expression for activity
of the SP-C promoter and, therefore, is consistent with the
). All rights reserved.
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gene expression.
DISCUSSION
Increased expression of TTF-1 in alveolar type II cells caused
dose-dependent alterations in alveolar morphology, epithelial
FIG. 5. Inflammation in the Hi (1/2), Lo (1/1) bitransgenic mic
were composed primarily of eosinophils (arrowheads; A), which w
Cytospins of inflammatory cells recovered by bronchoalveolar lavag
macrophages (C). Very few neutrophils were found in either cytos
recovered by bronchoalveolar lavage revealed that 70% of the c
neutrophils (N) (D). Original magnification of (A) and (B), 8003; (C
FIG. 6. Immunohistochemistry for cellular proliferation using
biotinylated mouse monoclonal antibody as described in Methods.
localized in the cell nucleus. No PCNA staining was detected in the
or Hi (1/2) transgenic mice (data not shown). In the bitransgeni
(arrowheads) and PCNA-positive, alveolar epithelial cells with cond
cells are illustrated at a higher magnification in (B). Only rarely w
emphysematous, centrolobular regions of the lungs from these mi
lungs of the Hi (1/2), Lo (1/1) bitransgenic mice (D, E), includin
inflammatory cells (arrows), and presumptive fibroblasts with elon
of fibrosis (arrowheads, F). Figures are representative of n . 4 anima
the original magnification, 4403.
FIG. 7. Developmental progression of the histopathological find
nontransgenic littermate controls (A). Alveologenesis was delayed
(1/2) bitransgenic mice (C). Acute eosinophilic inflammation wit
bitransgenic mice at this time point. Figures are representative
magnification of all panels, 1103.
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Although the SP-C-Ttf1 transgene failed to rescue the severe
pulmonary hypoplasia typical of the Ttf1 (2/2) mice, in-
creased expression of TTF-1 did not alter prenatal lung forma-
tion but caused abnormalities in alveolarization in the post-
natal period. The present study demonstrates that precise
temporal–spatial expression of TTF-1 is required for normal
ammatory infiltrates in the Hi (1/2), Lo (1/1) bitransgenic mice
munopositive for eosinophil major basic protein (arrowheads; B).
re composed primarily of eosinophils (arrowheads) and large foamy
or tissue sections. Differential cell counts of inflammatory cells
ere eosinophils (E), 25% were macrophages (M), and 5% were
003.
A antibody. PCNA was detected by immunostaining with a
A staining was detected as a black precipitation product that was
olar epithelium of wild-type (WT) littermate controls or in Lo (1/2)
(1/2), Lo (1/2) mice, focal areas of PCNA-positive type II cells
d nuclei (arrows) were found in the periphery of the lung (A). These
there any PCNA-positive cells (arrowhead) detected in the more
). In contrast, PCNA-positive cells were detected throughout the
NA-positive alveolar epithelial cells (arrowheads), PCNA-positive
PCNA-positive nuclei, which were found in multiple focal areas
r genotype. Original magnification of (B), 8803; for all other panels,
Alveolar septation was nearly complete at 14 days after birth in
e Hi (1/2) transgenic mice (B) and disrupted in the Hi (1/2), Lo
al areas of fibrosis (arrow) was observed in the Hi (1/2), Lo (1/1)
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84 Wert et al.postnatal lung maturation. A surprising link between the
expression of TTF-1, a nuclear transcription factor expressed
only in epithelial cells, and recruitment of inflammatory cells
FIG. 8. In situ hybridization analysis for transgene expression in t
hybridization using [35S] labeled TPA sense and anti-sense riboprob
illumination. No hybridization signals were detected for transgene
transgene mRNA expression were detected throughout the alveolar
the Hi (1/2) copy transgene, there was an increase in the number o
strength (C). A mixture of scattered foci of cells exhibiting either w
found in the Hi (1/2), Lo (1/2) bitransgenic mice (D). Intense hyb
the lungs of Hi (1/2), Lo (1/1) bitransgenic mice, while regions of
signals were detected when tissue from the latter genotype was hybr
PA, pulmonary artery. Figures are representative of n . 4 animalswas observed in mice bearing the highest copy number of the
© 2002 Elsevier Science (USAtransgene, supporting unexpected relationships between tran-
scriptional control of respiratory epithelial cell proliferation,
differentiation, and function (via TTF-1) and inflammation
ng. Distribution of the SP-C-Ttf1 transgene was analyzed by in situ
described in Methods. Results were photographed with dark field
ssion in nontransgenic littermate controls (A). Uniform signals for
ns of mice expressing the Lo (1/2) copy transgene (B). In mice with
olar cells expressing the transgene, as well as an increase in signal
, intense, or no hybridization signals for transgene expression was
tion signals for transgene mRNA were found in fibrotic regions of
e inflammation lacked transgene expression (E). No hybridization
d with the radiolabeled TPA sense control probe (F). Br, bronchiole;
genotype. Original magnification for all panels, 443.he lu
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idizeand alveolar remodeling.
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Ttf1 (2/2) Hypoplastic Lungs
The SP-C-Ttf1 transgene failed to rescue the severe pul-
monary hypoplasia typical of the Ttf1 (2/2) mice. This
finding perhaps is not surprising, since in vitro studies
demonstrated that TTF-1 itself is required for transcrip-
tional activity of the SP-C promoter (Kelly, 1996), while in
vivo studies demonstrated that SP-C is not detected in Ttf1
(2/2) mice (Tichelaar et al., 1999). The human SP-C
promoter is active as early as day 9.5–10 of gestation, while
the endogenous mouse SP-C mRNA is readily detectable as
early as day 10–11 of gestation (Glasser, 1991; Wert, 1993).
TTF-1 protein is detected at post-conception 9–9.5 in the
lung buds at sites consistent with those of SP-C expression
(Zhou, 1996a). The failure of the transgene to rescue the
hypoplastic lungs of the Ttf1 (2/2) mice suggests that
either TTF-1 is required for the activation of the SP-C-Ttf1
transgene or the commitment of cells to lineages expressing
SP-C has not occurred in the embryonic lung in the absence
of TTF-1. This result supports the concept that TTF-1 is an
upstream regulator required for commitment and prolifera-
tion of cells forming the alveolar parenchyma, as well as for
the expression of the surfactant proteins.
TTF-1 Regulation of SP-B Expression
TTF-1 has been shown to be an important transcriptional
regulator of the SP-B gene (Bohinski, 1994). In this study,
increased cellular staining and secretion of SP-B was corre-
lated with TTF-1 expression. Increased SP-B staining was
observed in Hi (1/2) transgenic mice in the absence of
inflammation, as well as in bitransgenic mice with emphy-
sema and/or severe eosinophilic inflammation. Increased
and/or decreased cellular staining patterns for TTF-1 and
SP-B were associated in all genotypes, as well as within
various histopathological lesions, suggesting that a very
tight linkage exists between the expression of these two
genes.
Alveolar Abnormalities in SP-C-Ttf1 Transgenic
Mice
Gene dose-dependent abnormalities in lung morphology
were consistently observed in the alveolar regions of SP-C-
Ttf1 transgenic mice. In spite of the fact that the SP-C-Ttf1
transgene is active during lung development (data not
shown), no abnormalities in branching morphogenesis or
lung structure were observed in the transgenic mice at
E18.5, regardless of gene dosage. Since levels of TTF-1 are
normally high in the developing lung (Morotti, 2000; Stahl-
man, 1996; Zhou, 1996a, 2001), expression of the SP-C-Ttf1
transgene in cells expressing high levels of endogenous
TTF-1 did not appear to perturb lung morphogenesis. How-
ever, sustained high concentrations of TTF-1 later in post-
natal development, when endogenous levels of TTF-1 de-
crease, perturbed alveolarization in the SP-C-Ttf1
bitransgenic mice.
© 2002 Elsevier Science (USAEffects of TTF-1 on lung morphogenesis were clearly
evident during the postnatal period of alveolarization, a
process that is highly active between postnatal days 5 and
14 in the mouse (Amy, 1977). In the normal lung, the levels
of TTF-1 decrease dramatically in the postnatal period
(Morotti, 2000; Stahlman, 1996; Zhou, 1996a, 2001), ulti-
mately being detected in type II epithelial cells but not in
type I epithelial cells, the latter comprising an increasing
proportion of the lung parenchyma in the postnatal period
of development. Disruption of alveolarization suggests that
precise temporal–spatial regulation of TTF-1 is required for
maturation and maintenance of alveolar structures.
Increased expression of TTF-1 caused type II cell hyper-
plasia in the Hi (1/2) transgenic mice, indicated by clusters
of SP-B-positive type II epithelial cells at alveolar sites
normally containing single type II cells. These findings
support the concept that TTF-1 influences type II cell
proliferation and differentiation or, alternatively, inhibits
the differentiation of type II to type I epithelial cells.
Similar type II cell hyperplasia was previously observed in
transgenic mice expressing the SV40 large T gene driven by
the SP-C promoter (Wikenheiser, 1998). In that model, type
II cell hyperplasia was associated with emphysema and
altered alveolarization prior to tumor formation. The
present findings support the concept that decreased TTF-1
activity may be critical for type II-to-type I cell differentia-
tion, which accompanies alveolarization. Thus, persis-
tently increased expression of TTF-1 in the postnatal lung
may disrupt normal epithelial cell proliferation and differ-
entiation, leading to cell loss and emphysema. This hypoth-
esis is supported by the findings in the Hi (1/2), Lo (1/2)
bitransgenic mice, where foci of PCNA staining cells with
condensed nuclei were found in peripheral regions of the
lung undergoing remodeling and loss of epithelial cells.
Whether the remodeling process represents activation of
apoptotic or abnormal proliferative pathways is unclear at
present.
Severe inflammation and fibrosis were observed in lungs
of Hi (1/2), Lo (1/1) bitransgenic mice in the absence of
infection or pathogens. Cell proliferation was associated
with high levels of TTF-1 expression in fibrotic regions of
the lung, but was generally decreased in areas associated
with inflammation and acute alveolar injury. This histopa-
thology is similar to that of lungs undergoing repair in
response to injury or following exposure to proliferative
stimuli. For example, increased expression of fibroblast
growth factors FGF-7 and FGF-10 caused type II cell hyper-
plasia that was associated with increased staining for
TTF-1, as well as for the surfactant proteins (Clark, 2001;
Tichelaar, 2000). Increased TTF-1 staining was also ob-
served in regenerating regions of human lung following
infection, neonatal respiratory distress syndrome, and bron-
chopulmonary dysplasia (Stahlman, 1996). Thus, increased
expression of TTF-1 may play a role in repair of the lung
following injury.
In the present studies, epithelial cell hyperplasia, in-
creased cytokine production, and inflammation were asso-
). All rights reserved.
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were observed following exposure of the adult lung to
members of the FGF family of polypeptides (Clark, 2001;
Tichelaar, 2000). FGF-induced hyperplasia was accompa-
nied by macrophage infiltration, increased expression of
TTF-1, surfactant proteins, and proinflammatory cytokines
and chemokines. Since a number of cytokines, including
IL-6, IL-1b, MIP-2, and TNF-a, cause inflammation and
remodeling when expressed in the lung (DiCosmo, 1994;
Kuhn, 2000; Miyazaki, 1995; Sueoka, 1998), their induction
by TTF-1 may contribute to the morphological abnormali-
ties observed in the SP-C-Ttf1 bitransgenic mice. In the
present study, inflammatory cell infiltrates in the Hi (1/2),
Lo (1/1) bitransgenic mice consisted primarily of eosino-
phils and foamy macrophages. Markedly increased concen-
trations of eotaxin and IL-6 were also observed in the BALF
fluid from these mice. While IL-6 is synthesized in inflam-
matory cells, fibroblasts, and endothelial cells, eotaxin is
expressed primarily in the epithelium of the lung (Cook,
1998; Lilly, 1997). Although it is unclear at present whether
changes in eotaxin or IL-6 contributed to the emphysema
and fibrosis observed in the SP-C-Ttf1 mice, the present
studies support the concept that TTF-1 may influence gene
transcription, directly and/or indirectly, to enhance the
expression of selected chemokines and/or cytokines, which
mediate inflammatory responses in the lung. Thus, TTF-1
appears to regulate type II cell proliferation, differentiation,
and function in complex ways that may influence the
expression of proinflammatory or signaling molecules in-
volved in the process of host defense and repair of the lung.
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